Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126096 · ClinicalTrials.gov registry record · NA
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 747
- Enrollment target
NCT04126096: Completed NA study, sponsored by Mayo Clinic.
NCT04126096 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 747 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126096, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 747 participants
- Enrollment target
Study Summary
The researchers are trying to evaluate how much medication is required for allergy skin testing and to determine the likelihood that patients with a negative test truly don't have an allergy to the tested drug of skin testing to commonly used antibiotics.
Interventions
- DIAGNOSTIC_TEST Skin Testing beta-lactams
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 747 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2023-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126096
The ClinicalTrials.gov registry entry for NCT04126096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 747 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Skin Testing beta-lactams is the first listed.
NCT04126096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04126096 about?
NCT04126096 is a clinical study titled "Negative Predictive Value and NIC of Beta-Lactam Antibiotics.". The researchers are trying to evaluate how much medication is required for allergy skin testing and to determine the likelihood that patients with a negative test truly don't have an allergy to the tested drug of skin testing to commonly used antibiotics.
What is the current status of trial NCT04126096?
This trial is currently completed. It is a NA study. The enrollment target is 747 participants. The study started on 2019-09-20. Estimated completion is 2023-01-06.
What interventions are being tested in trial NCT04126096?
The interventions under investigation include: Skin Testing beta-lactams (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04126096?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.